Newsletter Winter 2005

• Stem Cell Research in Parkinson's Disease-P.1
• President’s Message-P.2
• Stalevo Inital Therapy-P.2
• Q & A -P.4
• F.Y.I -P.5-8
• Executive Functions-P.9
• Neuroprotection Trials in PD-P.10
• Music Therapy-P.10
• FDA Approves Enablex for Treatment of Overactive Bladder-P.11
• Exelon and Parkinson's Disease-P.12
• Educational Material-P.12